Novo Holdings A/S - 21 Mar 2024 Form 4 Insider Report for SPRUCE BIOSCIENCES, INC. (SPRB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
25 Mar 2024, 21:45:53 UTC
Prior SEC filing
20 Mar 2024
Next SEC filing
14 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Barbara Fiorini Due, General Counsel, Finance & Operations

Key filing fact

Novo Holdings A/S filed Form 4 for SPRUCE BIOSCIENCES, INC. (SPRB) on 25 Mar 2024.

Key facts

  • This page summarizes Novo Holdings A/S's Form 4 filing for SPRUCE BIOSCIENCES, INC. (SPRB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 25 Mar 2024, 21:45.

Change

  • Previous filing in this sequence was filed on 20 Mar 2024.
  • Current net transaction value: -$350,951.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SPRB transaction

COMMON STOCK

Sale

Transaction value
$350,951
Shares
-465,021
Change %
-15%
Price
$0.7547
Shares after
2,550,000
Date
21 Mar 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Novo Holdings A/S is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.71 to $0.7785, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .